Entera Bio Ltd.

( )
ENTX After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Major
ABBVAbbVie, Inc. 2.34%93.021.9%$1186.74m
BMYBristol-Myers Squibb Co. 1.11%60.881.0%$1017.89m
JNJJohnson & Johnson -1.29%146.730.7%$981.40m
PFEPfizer Inc. -0.43%36.010.9%$952.53m
MRKMerck & Co., Inc. -0.62%81.550.7%$859.75m
LLYEli Lilly & Co. -1.19%150.711.1%$518.38m
AZNAstraZeneca Plc -2.04%53.881.2%$285.14m
NVSNovartis AG -0.69%85.110.2%$148.55m
GSKGlaxoSmithKline Plc -1.12%41.650.2%$128.42m
NVONovo Nordisk A/S -0.57%64.340.1%$86.12m
SNYSanofi 0.75%49.950.2%$77.97m
RGENRepligen Corp. -4.19%121.827.1%$69.06m
BHVNBiohaven Pharmaceutical Holding Co. Ltd. 1.71%67.410.0%$52.59m
TPTXTurning Point Therapeutics, Inc. -11.41%62.190.0%$36.90m
RETAReata Pharmaceuticals, Inc. -4.35%129.533.4%$36.23m

Company Profile

Entera Bio Ltd. is a clinical-stage biopharmaceutical company, which focuses on the development and commercialization of orally delivered large molecule therapeutics. It develops an oral formulation of parathyroid hormone. The company was founded on June 1, 2010 and is headquartered in Jerusalem, Israel.